Immunocal
70 International "Method of Use" Patents.
Before we look at the actual patents that have been registered for Immunocal, it is critically important to recognize a few factors that set our product apart from ANY OTHER NEUTRACEUTICAL on the market.
You can see that we make specific reference to the fact that the Immunocal Patents are "METHOD OF USE" Patents.
Since most of the population knows what a "PATENT" is, this does not have to be explained.
However, most of the population DOES NOT KNOW what a "Method of Use" Patent is. So, here is the difference;
Just about anything can be patented by anyone, for things like; a new invention, a new way to manufacture something or a new blend of ingredients, all for a particular product that someone has created. These are very good patents for protecting something, so that it cannot be legally reproduced by someone else.
"Method of Use" Patents on the other hand are normally restricted to drugs because they actually state a specific result which has been proven scientifically, with Medical Community Standards of Research needed before they can be registered.
This is what sets Immunotec Research and Immunocal apart from the rest of the products and companies.
This is what allows you to rest assured that you are consuming the BEST PRODUCT available for YOUR IMMUNE SYSTEM, guaranteeing YOU that by consuming Immunocal, you are increasing your critical intracellular glutathione.
North & South America
Argentina
Canada
Chile
Mexico
United States
Europe to Africa
Austria
Czech Republic
Denmark
Europe
Germany
Israel
Italy
Norway
South Africa
Spain
Sweden
United Kingdom
Asia - Australia & New Zealand
Australia
China
Japan
New Zealand
Singapore
South Korea
Taiwan
Please CLICK the country flag above to view our PatentsNote: the original patents and research were done in Canada and the USA. You will notice some countries have patented all, while others have chosen to be conservative and only patent either the; Anti-cancer, HIV treatment or Immune Response patents, with the exception of Singapore. More patents will come, we are just getting started internationally...
Immunotec Inc. congratulates Dr. Luc Montagnier for winning the 2008 Nobel Prize in Medicine for his 1984 discovery, with Françoise Barré–Sinoussi, of the Human Immunodeficiency Virus (HIV).
Drs. Montagnier and Barré-Sinoussi first understood that HIV “impaired the immune system because of massive virus replication and cell damage to lymphocytes.” Their seminal work set the stage for understanding the biology of the disease and current modalities of treatment. In addition, it led to development of methods of diagnosis and blood screening that has mitigated the spread of the disease.
Dr. Montagnier and his colleagues edited Oxidative Stress in Cancer, AIDS, and Neurodegenerative Diseases, devoting an entire chapter to a paper co-authored by Immunotec founding scientist Dr. Gustavo Bounous, entitled;
Nutriceutical Modulation of Glutathione with a Humanized Native Milk Serum Protein Isolate, Immunocal: Application in AIDS and Cancer,
70 International "Method of Use" Patents.
| Before we look at the actual patents that have been registered for Immunocal, it is critically important to recognize a few factors that set our product apart from ANY OTHER NEUTRACEUTICAL on the market. You can see that we make specific reference to the fact that the Immunocal Patents are "METHOD OF USE" Patents. Since most of the population knows what a "PATENT" is, this does not have to be explained. However, most of the population DOES NOT KNOW what a "Method of Use" Patent is. So, here is the difference; Just about anything can be patented by anyone, for things like; a new invention, a new way to manufacture something or a new blend of ingredients, all for a particular product that someone has created. These are very good patents for protecting something, so that it cannot be legally reproduced by someone else. "Method of Use" Patents on the other hand are normally restricted to drugs because they actually state a specific result which has been proven scientifically, with Medical Community Standards of Research needed before they can be registered. This is what sets Immunotec Research and Immunocal apart from the rest of the products and companies. This is what allows you to rest assured that you are consuming the BEST PRODUCT available for YOUR IMMUNE SYSTEM, guaranteeing YOU that by consuming Immunocal, you are increasing your critical intracellular glutathione. |
Argentina | Canada | Chile | Mexico | United States |
Europe to Africa
Austria | Czech Republic | Denmark | Europe | Germany | ||
Israel | Italy | Norway | South Africa | Spain | Sweden | United Kingdom |
Asia - Australia & New Zealand
Australia | China | Japan | New Zealand | Singapore | South Korea | Taiwan |
Please CLICK the country flag above to view our Patents
| Note: the original patents and research were done in Canada and the USA. You will notice some countries have patented all, while others have chosen to be conservative and only patent either the; Anti-cancer, HIV treatment or Immune Response patents, with the exception of Singapore. More patents will come, we are just getting started internationally... |
|
|
| ||
|
|
Immunotec Inc. congratulates Dr. Luc Montagnier for winning the 2008 Nobel Prize in Medicine for his 1984 discovery, with Françoise Barré–Sinoussi, of the Human Immunodeficiency Virus (HIV). Drs. Montagnier and Barré-Sinoussi first understood that HIV “impaired the immune system because of massive virus replication and cell damage to lymphocytes.” Their seminal work set the stage for understanding the biology of the disease and current modalities of treatment. In addition, it led to development of methods of diagnosis and blood screening that has mitigated the spread of the disease.Dr. Montagnier and his colleagues edited Oxidative Stress in Cancer, AIDS, and Neurodegenerative Diseases, devoting an entire chapter to a paper co-authored by Immunotec founding scientist Dr. Gustavo Bounous, entitled; Nutriceutical Modulation of Glutathione with a Humanized Native Milk Serum Protein Isolate, Immunocal: Application in AIDS and Cancer, |
